研究開発費 - その他、販売金融債権の増減額（△は増加）、非支配持分
- 【期間】
| 年度 | 研究開発費 - その他 | 販売金融債権の増減額（△は増加） | 非支配持分 |
|---|
| 2015/03 | - | | - | | - | |
| 2015/06 | - | | - | | - | |
| 2015/09 | - | | - | | - | |
| 2015/12 | - | | - | | - | |
| 2016/03 | - | | - | | - | |
| 2016/06 | - | | - | | - | |
| 2016/09 | - | | - | | - | |
| 2016/12 | - | | - | | - | |
| 2017/03 | - | | - | | - | |
| 2017/06 | - | | - | | - | |
| 2017/09 | - | | - | | - | |
| 2017/12 | - | | - | | - | |
| 2018/03 | - | | - | | - | |
| 2018/06 | - | | - | | - | |
| 2018/09 | - | | - | | - | |
| 2018/12 | - | | - | | - | |
| 2019/03 | - | | - | | - | |
| 2019/06 | - | | - | | - | |
| 2019/09 | - | | - | | - | |
| 2019/12 | 66億 | | - | | - | |
| 2020/03 | - | | - | | - | |
| 2020/06 | - | | - | | - | |
| 2020/09 | - | | - | | - | |
| 2020/12 | 27億 | -59.1% | - | | - | |
| 2021/03 | - | | - | | - | |
| 2021/06 | - | | - | | - | |
| 2021/09 | - | | - | | - | |
| 2021/12 | 23億 | -14.8% | - | | - | |
| 2022/03 | - | | - | | - | |
| 2022/06 | - | | - | | - | |
| 2022/09 | - | | - | | - | |
| 2022/12 | 27億 | +17.4% | - | | - | |
| 2023/03 | - | | -629億 | | 46.4億 | |
| 2023/06 | - | | -812億 | 赤拡 | 122億 | +164.1% |
| 2023/09 | - | | -910億 | 赤拡 | 169億 | +37.8% |
| 2023/12 | 49億 | +81.5% | -1230億 | 赤拡 | 197億 | +16.9% |
| 2024/03 | - | | -610億 | 赤縮 | 76.5億 | -61.2% |
| 2024/06 | - | | -709億 | 赤拡 | 147億 | +92% |
| 2024/09 | - | | -521億 | 赤縮 | 132億 | -9.8% |
| 2024/12 | 59億 | +20.4% | -622億 | 赤拡 | 193億 | +45.8% |
| 2025/03 | - | | -635億 | 赤拡 | 4.18億 | -97.8% |
